Comment from Brooke Orosz

The new mRNA flu vaccines offer a solution to the worst problem with current-generation flu vaccines: long lead times for manufacturing leading to bad-match years. I eagerly await approval based on the data already submitted, and rejecting the new vaccine would be evidence of corruption and political bias.